Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Behandlingsniveau og behandlingsstop ved benign lungesygdom

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Svær adenoviruspneumoni hos en immunkompetent mand

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Allergisk kontakteksem ved anvendelse af insulinpumper og glukosesensorer hos børn med diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Remdesivir til behandling af COVID-19-pneumoni

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Stilheden før stormen - om psykiatrisk sygdom i coronaens tid

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Varicocele Testis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.

Translated title of the contributionTreatment limitations or discontinuation in patients with benign pulmonary diseases
Original languageDanish
JournalUgeskrift for Laeger
Volume180
Issue number39
ISSN0041-5782
Publication statusPublished - 24 Sep 2018

ID: 56582120